🇺🇸 FDA
Patent

US 9314448

Method of inhibiting ABCG2 and other treatment methods

granted A61KA61K31/165A61K31/277

Quick answer

US patent 9314448 (Method of inhibiting ABCG2 and other treatment methods) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/165, A61K31/277, A61K31/353, A61P